ICU · Healthcare · $11M
$3.56+4.71%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 326 Biotechnology peers
Quarterly Revenue Growth
“매출이 61만5000달러로 전년 동기 대비 82% 늘었고, 성장률도 전 분기 69%에서 더 빨라졌어요.”
In the company's words · 2026 2분기 earnings call